Search

Duane L Charbonneau

from Loveland, OH
Age ~68

Duane Charbonneau Phones & Addresses

  • 130 Overlook Dr, Loveland, OH 45140 (513) 850-1401
  • 7983 Hedgewood Cir, Mason, OH 45040 (513) 398-3389 (513) 398-5326
  • 5102 Sunburst Way, Mason, OH 45040 (513) 398-5326
  • Bloomington, IN
  • Liberty Township, OH
  • Crescent Springs, KY
  • Des Moines, IA
  • Lebanon, OH
  • Warren, OH

Resumes

Resumes

Duane Charbonneau Photo 1

Duane Charbonneau

View page

Publications

Us Patents

Compositions Comprising Nitrofurantoin And Uva Ursi

View page
US Patent:
6521270, Feb 18, 2003
Filed:
May 7, 2002
Appl. No.:
10/139839
Inventors:
Kevin Douglas Taylor - Mason OH
Duane Larry Charbonneau - Lebanon OH
Assignee:
The Procter Gamble Company - Cincinnati OH
International Classification:
H61K 3578
US Classification:
424725, 514579
Abstract:
Compositions and kits comprising nitrofurantoin and uva ursi are effective for treating infectious disorders, particularly urinary tract infections, cystitis, and pyclonephritis.

Compositions Comprising Nitrofurantoin And Uva Ursi

View page
US Patent:
6602525, Aug 5, 2003
Filed:
Dec 18, 2002
Appl. No.:
10/323440
Inventors:
Kevin Douglas Taylor - Mason OH
Duane Larry Charbonneau - Lebanon OH
Assignee:
The Procter Gamble Company - Cincinnati OH
International Classification:
A61K 3578
US Classification:
424725, 514579
Abstract:
Compositions and kits comprising nitrofurantoin and uva ursi are effective for treating infectious disorders, particularly urinary tract infections, cystitis, and pyelonephritis.

Stabilized Compositions Comprising A Probiotic

View page
US Patent:
20050100559, May 12, 2005
Filed:
Nov 7, 2003
Appl. No.:
10/704253
Inventors:
Graham Myatt - Camberley, GB
Duane Charbonneau - Mason OH, US
Kevin Wright - Frimley Green, GB
Martin Hallissey - Laleham, GB
International Classification:
A61K039/02
US Classification:
424234100, 424780000
Abstract:
Stabilized dry bacterial compositions comprising greater than 10% dried bacterial concentrate having a concentration of bacteria of at least 1×10cfu/g are provided. The compositions have improved stability. Also provided are packaged bacterial compositions, unit-dose compositions and methods of manufacturing the compositions provided herein.

Stabilised Compositions Comprising Probiotics

View page
US Patent:
20080145341, Jun 19, 2008
Filed:
Feb 19, 2008
Appl. No.:
12/033288
Inventors:
Graham John Myatt - Camberley, GB
Duane Larry Charbonneau - Mason OH, US
Kevin Ian Trevor Wright - Frimley Green, GB
Martin Hallissey - Laleham, GB
International Classification:
A61K 35/74
C12N 1/20
A61P 43/00
US Classification:
424 934, 4352521, 4352534, 4352529
Abstract:
Stabilised dry bacterial compositions comprising greater than 10% dried bacterial concentrate having a concentration of bacteria of at least 1×10cfu/g are provided. The compositions have improved stability. Also provided are packaged bacterial compositions, unit-dose compositions and methods of manufacturing the compositions of the present invention.

Methods And Kits For Administering Probiotics

View page
US Patent:
20080241226, Oct 2, 2008
Filed:
Mar 27, 2008
Appl. No.:
12/056702
Inventors:
Susan L. Abeln - Loveland OH, US
Duane Larry Charbonneau - Mason OH, US
Ker-Sang Chen - West Chester OH, US
James Patrick Ebel - Lebanon OH, US
Mary Elaine Freeland - Loveland OH, US
International Classification:
A61K 9/00
A61K 35/74
US Classification:
424439, 424 934
Abstract:
Methods for administering probiotics comprising the steps of: administering a loading dose of a loading probiotic for a loading time period; and administering a dose of a botanical and/or additional materials for the loading time period are disclosed. The methods also include administering a maintenance dose of a maintenance probiotic, and/or a botanical and/or an additional material for a maintenance time period. Also disclosed are kits for use in administering probiotics.

Bifidobacterium Longum

View page
US Patent:
20100183559, Jul 22, 2010
Filed:
Nov 11, 2009
Appl. No.:
12/616752
Inventors:
Douwe Van Sinderen - Carrigrohane, IE
Jun Xu - Mason OH, US
Wenzhu (Steven) Zhao - Mason OH, US
Raymond A. Grant - Fairfield OH, US
Song Yuli - Mason OH, US
Charles Bascom - Hamilton MA, US
Duane Larry Charbonneau - Mason OH, US
Liam O'Mahony - Rathcormac, IE
Assignee:
Alimentary Health Limited - Kinsale Road
The Procter & Gamble Company - Cincinnati OH
International Classification:
A61K 35/74
C12N 1/21
C12Q 1/68
US Classification:
424 932, 4352523, 424780, 435 6
Abstract:
The multiple embodiments described herein comprise the genome of a probiotic bifidobacteria strain and genes encoded by the genome. Various novel are described.

Method Of Identifying Prebiotics And Compositions Containing The Same

View page
US Patent:
20130115610, May 9, 2013
Filed:
Nov 8, 2012
Appl. No.:
13/672163
Inventors:
Duane Larry CHARBONNEAU - Mason OH, US
Brian Wilson HOWARD - Mason OH, US
Assignee:
The Procter & Gamble Company - Cincinnati OH
International Classification:
C12Q 1/02
US Classification:
435 612, 435 29, 435 792
Abstract:
A method for identifying test agents that exhibit prebiotic activity on human skin commensal microorganisms and compositions that include such agents. The method includes providing a test culture of a test agent, a human skin commensal microorganism and a minimal carbon medium. The method provides a time efficient and cost effective way to predict in vivo prebiotic activity of a test agent on skin commensal microorganisms.

Method Of Identifying Prebiotics And Compositions Containing The Same

View page
US Patent:
20130115648, May 9, 2013
Filed:
Nov 8, 2012
Appl. No.:
13/672211
Inventors:
Duane Larry CHARBONNEAU - Mason OH, US
Brian Wilson HOWARD - Mason OH, US
Assignee:
THE PROCTER & GAMBLE COMPANY - Cincinnati OH
International Classification:
C12Q 1/02
US Classification:
435 29
Abstract:
A high-throughput, tiered screening method of indentifying test agents that exhibit prebiotic activity on human skin commensal microorganisms and cosmetic compositions that include such agents. The method includes determining the metabolite level of a culture and comparing the metabolite level to a control value. The assay further comprises performing a plate count using the culture when the metabolite level of the culture is greater than its corresponding control value. The plate count results are compared to another control value, and the test agent is identified as a prebiotic agent when the number of colonies present in the plate count assay of the culture is greater than the second control value.
Duane L Charbonneau from Loveland, OH, age ~68 Get Report